HEXCLAD ANNOUNCES F1 DRIVER YUKI TSUNODA AS GLOBAL AMBASSADOR
Tsunoda Joins
Tsunoda, known for his fearless driving style and standout personality, is also a passionate home cook who has long dreamed of becoming a chef. Now, he's teaming up with
"Food and cooking are a huge part of my life, and I love spending time in the kitchen," said
Tsunoda joins HexClad's growing ambassador lineup, led by Ramsay, who trust the brand's patented hybrid cookware for its unmatched durability, performance and design. As part of the partnership, Tsunoda will appear in global campaign content throughout the 2025 F1 season, spotlighting how HexClad supports his life off the track with the same attention to performance he brings to every race. He will also sport the HexClad brand logo on his race helmet at one race this season.
"Yuki is an incredible athlete, but what makes him perfect for HexClad is his mindset. He's passionate, precise and all in," said
The announcement follows a wave of momentum for HexClad, which continues to expand globally and redefine how performance-driven cooking tools are driving the industry. With Tsunoda onboard, the brand deepens its presence in both the culinary world and the global sports spotlight.
The campaign, concepted by HexClad and produced by KODE Media under the direction of
To learn more, visit www.hexclad.com
About HexClad:
HexClad is a global premium kitchenware brand based in
View original content to download multimedia:https://www.prnewswire.com/news-releases/hexclad-announces-f1-driver-yuki-tsunoda-as-global-ambassador-302538278.html
SOURCE HexClad
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Anaergia Australia Pty Ltd. to Supply Advanced Anaerobic Digestion Technology for Goodness Grown Facility in Australia
- Trawick Holdings Introduces the United Kingdom’s First-Ever Cancel For Any Reason Travel Protection Service, Reshaping the Future of Flexible Travel Protection Across Europe
- ITM Announces Primary Results from the Phase 3 COMPETE Trial Published in The Lancet Comparing ¹⁷⁷Lu-edotreotide (ITM-11) vs. Everolimus in Advanced GEP-NETs
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share